These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 12740217

  • 21. Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.
    Hill GR, Teshima T, Gerbitz A, Pan L, Cooke KR, Brinson YS, Crawford JM, Ferrara JL.
    J Clin Invest; 1999 Aug; 104(4):459-67. PubMed ID: 10449438
    [Abstract] [Full Text] [Related]

  • 22. High levels of peroxynitrite are generated in the lungs of irradiated mice given cyclophosphamide and allogeneic T cells. A potential mechanism of injury after marrow transplantation.
    Haddad IY, Panoskaltsis-Mortari A, Ingbar DH, Yang S, Milla CE, Blazar BR.
    Am J Respir Cell Mol Biol; 1999 Jun; 20(6):1125-35. PubMed ID: 10340931
    [Abstract] [Full Text] [Related]

  • 23. Donor-derived TNF-alpha regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation.
    Hildebrandt GC, Olkiewicz KM, Corrion LA, Chang Y, Clouthier SG, Liu C, Cooke KR.
    Blood; 2004 Jul 15; 104(2):586-93. PubMed ID: 15069018
    [Abstract] [Full Text] [Related]

  • 24. Effects of oxidant stress on inflammation and survival of iNOS knockout mice after marrow transplantation.
    Yang S, Porter VA, Cornfield DN, Milla C, Panoskaltsis-Mortari A, Blazar BR, Haddad IY.
    Am J Physiol Lung Cell Mol Physiol; 2001 Oct 15; 281(4):L922-30. PubMed ID: 11557596
    [Abstract] [Full Text] [Related]

  • 25. Pulmonary T cell repertoire in patients with graft-versus-host disease following blood and marrow transplantation.
    Yurovsky VV, Cottler-Fox MH, Atamas SP, Shanholtz CB, Britt EJ, Sensenbrenner LL, White B.
    Am J Hematol; 2001 Jan 15; 66(1):1-11. PubMed ID: 11426485
    [Abstract] [Full Text] [Related]

  • 26. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L, Lubin I, Factorowich I, Lapidot Z, Reich S, Reisner Y, Slavin S.
    J Immunol; 1994 Sep 15; 153(6):2562-7. PubMed ID: 8077666
    [Abstract] [Full Text] [Related]

  • 27. Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.
    Jenq RR, King CG, Volk C, Suh D, Smith OM, Rao UK, Yim NL, Holland AM, Lu SX, Zakrzewski JL, Goldberg GL, Diab A, Alpdogan O, Penack O, Na IK, Kappel LW, Wolchok JD, Houghton AN, Perales MA, van den Brink MR.
    Blood; 2009 Feb 12; 113(7):1574-80. PubMed ID: 19011222
    [Abstract] [Full Text] [Related]

  • 28. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM, Waller EK.
    Biol Blood Marrow Transplant; 2004 Aug 12; 10(8):540-51. PubMed ID: 15282532
    [Abstract] [Full Text] [Related]

  • 29. Cobalt protoporphyrine IX-mediated heme oxygenase-I induction alters the inflammatory cytokine response, but not antigen presentation after experimental allogeneic bone marrow transplantation.
    Ewing P, Hildebrandt GC, Planke S, Andreesen R, Holler E, Gerbitz A.
    Int J Mol Med; 2007 Sep 12; 20(3):301-8. PubMed ID: 17671733
    [Abstract] [Full Text] [Related]

  • 30. A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation.
    Hildebrandt GC, Duffner UA, Olkiewicz KM, Corrion LA, Willmarth NE, Williams DL, Clouthier SG, Hogaboam CM, Reddy PR, Moore BB, Kuziel WA, Liu C, Yanik G, Cooke KR.
    Blood; 2004 Mar 15; 103(6):2417-26. PubMed ID: 14615370
    [Abstract] [Full Text] [Related]

  • 31. Surfactant homeostasis is maintained in vivo during keratinocyte growth factor-induced rat lung type II cell hyperplasia.
    Fehrenbach A, Bube C, Hohlfeld JM, Stevens P, Tschernig T, Hoymann HG, Krug N, Fehrenbach H.
    Am J Respir Crit Care Med; 2003 May 01; 167(9):1264-70. PubMed ID: 12574070
    [Abstract] [Full Text] [Related]

  • 32. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
    Jones MS, Riley R, Hamilton BL, Paupe J, Perez D, Levy RB.
    Bone Marrow Transplant; 1994 Nov 01; 14(5):725-35. PubMed ID: 7889005
    [Abstract] [Full Text] [Related]

  • 33. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y, Sachs DH, Khan A, Sykes M.
    Transplantation; 1996 Feb 15; 61(3):469-77. PubMed ID: 8610363
    [Abstract] [Full Text] [Related]

  • 34. Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients.
    Marks L, Altman NH, Podack ER, Levy RB.
    Transplantation; 2004 Mar 27; 77(6):804-12. PubMed ID: 15077018
    [Abstract] [Full Text] [Related]

  • 35. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O, Longo DL, Tian ZG, Hornung RL, Taub DD, Ruscetti FW, Murphy WJ.
    J Clin Invest; 1998 May 01; 101(9):1835-42. PubMed ID: 9576746
    [Abstract] [Full Text] [Related]

  • 36. Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation.
    Kaneda H, Adachi Y, Saito Y, Ikebukuro K, Machida H, Suzuki Y, Minamino K, Zhang Y, Iwasaki M, Nakano K, Koike Y, Wang J, Imamura H, Ikehara S.
    J Heart Lung Transplant; 2005 Sep 01; 24(9):1415-23. PubMed ID: 16143265
    [Abstract] [Full Text] [Related]

  • 37. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
    Zhao J, Zhao XY, Huang XJ.
    Zhonghua Yi Xue Za Zhi; 2005 Sep 14; 85(35):2497-502. PubMed ID: 16321278
    [Abstract] [Full Text] [Related]

  • 38. Induction of graft versus leukemia effects by cell-mediated lymphokine-activated immunotherapy after syngeneic bone marrow transplantation in murine B cell leukemia.
    Weiss L, Nusair S, Reich S, Sidi H, Slavin S.
    Cancer Immunol Immunother; 1996 Oct 14; 43(2):103-8. PubMed ID: 8954144
    [Abstract] [Full Text] [Related]

  • 39. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
    Cao J, Li L, Chen C, Zeng LY, Li ZY, Pan XY, Xu KL.
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb 14; 32(2):83-8. PubMed ID: 21429372
    [Abstract] [Full Text] [Related]

  • 40. Dexamethasone potentiates keratinocyte growth factor-stimulated SP-A and SP-B gene expression in alveolar epithelial cells.
    Mouhieddine-Gueddiche OB, Pinteur C, Chailley-Heu B, Barlier-Mur AM, Clement A, Bourbon JR.
    Pediatr Res; 2003 Feb 14; 53(2):231-9. PubMed ID: 12538780
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.